Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Capicua transcriptional repressor pseudogene 23 (CICP23)
- Target
- CICP23
- Molecular classification
- Other (Pseudogene)
01
Overview
Capicua transcriptional repressor pseudogene 23 (CICP23) is a human pseudogene that shares sequence similarity with the functional Capicua (CIC) transcription factor gene. Unlike functional genes, CICP23 does not encode a protein or contribute to canonical protein-mediated cellular functions. Pseudogenes can sometimes act as competitive endogenous RNAs or influence gene regulation through various non-coding RNA mechanisms, but there is no published evidence of such a function for CICP23 itself. Thus, it has no established biological, pathological, or pharmacological role, and is not recognized as a therapeutic target. If you require information on the functional capicua transcriptional repressor (CIC)—a transcription factor involved in development and disease—that is a different gene and may be considered a therapeutic target in specific contexts such as cancer.
- Other names
- Capicua transcriptional repressor pseudogene 23CICP23
02
Mechanism of action
Not applicable (as it does not encode a targetable protein or functional RNA product)
03
Biological functions
None established; as a pseudogene, no direct protein function is assigned. Some pseudogenes can regulate other genes or RNAs at the transcriptional or post-transcriptional level
04
Disease associations
None documented specifically for CICP23. Some pseudogenes can play roles in cancer or other diseases through regulatory mechanisms, but there is no evidence for CICP23 specifically
Beyond the preview
Go deeper on Capicua transcriptional repressor pseudogene 23 (CICP23).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Capicua transcriptional repressor pseudogene 23 (CICP23).